Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway

被引:132
作者
Kubota, Tetsuya [1 ,2 ,3 ,4 ]
Kubota, Naoto [1 ,2 ,3 ,4 ]
Kadowaki, Takashi [1 ,4 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138655, Japan
[2] RIKEN, Ctr Integrat Med Sci, Lab Metab Homeostasis, Yokohama, Kanagawa 2300045, Japan
[3] Natl Inst Hlth & Nutr, Clin Nutr Program, Tokyo 1628636, Japan
[4] Univ Tokyo, TSBMI, Tokyo 1538515, Japan
关键词
HEPATIC GLUCOSE-PRODUCTION; STIMULATES TYROSINE PHOSPHORYLATION; GROWTH-FACTOR-I; ACTIVATED PROTEIN-KINASE; ENDOTHELIAL NITRIC-OXIDE; AMINO-ACID POLYMORPHISMS; ELEMENT-BINDING PROTEIN; CENTRAL-NERVOUS-SYSTEM; BETA-CELL HYPERPLASIA; RECEPTOR SUBSTRATE 2;
D O I
10.1016/j.cmet.2017.03.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Since the discovery of the tyrosine kinase activity of the insulin receptor (IR), researchers have been engaged in intensive efforts to resolve physiological functions of IR and itsmajor downstream targets, insulin receptor substrate 1 (Irs1) and Irs2. Studies conducted using systemic and tissue-specific gene-knockout mice of IR, Irs1, and Irs2 have revealed the physiological roles of these molecules in each tissue and interactions among multiple tissues. In obesity and type 2 diabetes, selective downregulation of Irs2 and its downstream actions to cause reduced insulin actions was associated with increased insulin actions through Irs1 in variety tissues. Thus, we propose the novel concept of 'organ- and pathway-specific imbalanced insulin action'' in obesity and type 2 diabetes, which includes and extends "selective insulin resistance.'' This Review focuses on recent progress in understanding insulin signaling and insulin resistance using key mouse models for elucidating pathophysiology of human obesity and type 2 diabetes.
引用
收藏
页码:797 / 810
页数:14
相关论文
共 150 条
  • [31] THE HUMAN INSULIN-RECEPTOR CDNA - THE STRUCTURAL BASIS FOR HORMONE-ACTIVATED TRANSMEMBRANE SIGNALING
    EBINA, Y
    ELLIS, L
    JARNAGIN, K
    EDERY, M
    GRAF, L
    CLAUSER, E
    OU, JH
    MASIARZ, F
    KAN, YW
    GOLDFINE, ID
    ROTH, RA
    RUTTER, WJ
    [J]. CELL, 1985, 40 (04) : 747 - 758
  • [32] The Role of the Carbohydrate Response Element-Binding Protein in Male Fructose-Fed Rats
    Erion, Derek M.
    Popov, Violetta
    Hsiao, Jennifer J.
    Vatner, Daniel
    Mitchell, Kisha
    Yonemitsu, Shin
    Nagai, Yoshio
    Kahn, Mario
    Gillum, Matthew P.
    Dong, Jianying
    Murray, Susan F.
    Manchem, Vara Prasad
    Bhanot, Sanjay
    Cline, Gary W.
    Shulman, Gerald I.
    Samuel, Varman T.
    [J]. ENDOCRINOLOGY, 2013, 154 (01) : 36 - 44
  • [33] Clinical case seminar - A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling
    Esposito, DL
    Li, YH
    Vanni, C
    Mammarella, S
    Veschi, S
    Della Loggia, F
    Mariani-Costantini, R
    Battista, P
    Quon, MJ
    Cama, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) : 1468 - 1475
  • [34] Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis
    Fantin, VR
    Wang, Q
    Lienhard, GE
    Keller, SR
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 278 (01): : E127 - E133
  • [35] ANTIBODIES THAT IMPAIR INSULIN RECEPTOR-BINDING IN AN UNUSUAL DIABETIC SYNDROME WITH SEVERE INSULIN RESISTANCE
    FLIER, JS
    KAHN, CR
    ROTH, J
    BAR, RS
    [J]. SCIENCE, 1975, 190 (4209) : 63 - 65
  • [36] Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells
    Frasca, F
    Pandini, C
    Scalia, P
    Sciacca, L
    Mineo, R
    Costantino, A
    Goldfine, ID
    Belfiore, A
    Vigneri, R
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (05) : 3278 - 3288
  • [37] A family with severe insulin resistance and diabetes due to a mutation in AKT2
    George, S
    Rochford, JJ
    Wolfrum, C
    Gray, SL
    Schinner, S
    Wilson, JC
    Soos, MA
    Murgatroyd, PR
    Williams, RM
    Acerini, CL
    Dunger, DB
    Barford, D
    Umpleby, AM
    Wareham, NJ
    Davies, HA
    Schafer, AJ
    Stoffel, M
    O'Rahilly, S
    Barroso, I
    [J]. SCIENCE, 2004, 304 (5675) : 1325 - 1328
  • [38] Increased MAPK Activation and Impaired Insulin Signaling in Subcutaneous Microvascular Endothelial Cells in Type 2 Diabetes: The Role of Endothelin-1
    Gogg, Silvia
    Smith, Ulf
    Jansson, Per-Anders
    [J]. DIABETES, 2009, 58 (10) : 2238 - 2245
  • [39] Contributions of the American Journal of Physiology to the discovery of insulin
    Goldfine, ID
    Youngren, JF
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1998, 274 (02): : E207 - E209
  • [40] Hepatic Insulin Signaling Is Required for Obesity-Dependent Expression of SREBP-1c mRNA but Not for Feeding-Dependent Expression
    Haas, Joel T.
    Miao, Ji
    Chanda, Dipanjan
    Wang, Yanning
    Zhao, Enpeng
    Haas, Mary E.
    Hirschey, Matthew
    Vaitheesvaran, B.
    Farese, Robert V., Jr.
    Kurland, Irwin J.
    Graham, Mark
    Crooke, Rosanne
    Foufelle, Fabienne
    Biddinger, Sudha B.
    [J]. CELL METABOLISM, 2012, 15 (06) : 873 - 884